{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T04:29:20Z","timestamp":1778732960493,"version":"3.51.4"},"reference-count":20,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CMAR"],"DOI":"10.2147\/cmar.s276519","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T21:58:11Z","timestamp":1602021491000},"page":"9713-9719","source":"Crossref","is-referenced-by-count":5,"title":["<p>Survival and Clinical Outcomes with Telotristat Ethyl in Patients with Carcinoid Syndrome<\/p>"],"prefix":"10.2147","volume":"Volume 12","author":[{"given":"David C","family":"Metz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7422-6809","authenticated-orcid":true,"given":"Vijay N","family":"Joish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0253-325X","authenticated-orcid":true,"given":"Todor I","family":"Totev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5035-6687","authenticated-orcid":true,"given":"Mei Sheng","family":"Duh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiernan","family":"Seth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3982-0300","authenticated-orcid":true,"given":"Susan","family":"Giacalone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0704-0251","authenticated-orcid":true,"given":"Pablo","family":"Lapuerta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A","family":"Morse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,10]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/j.1464-410X.2006.06056.x","volume":"97","author":"Siddiqui","year":"2006","journal-title":"BJU Int"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.2217\/fon-2018-0960","volume":"15","author":"Joish","year":"2019","journal-title":"Future Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1046\/j.1471-4159.2001.00536.x","volume":"78","author":"Diksic","year":"2001","journal-title":"J Neurochem"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/CCO.0000000000000035","volume":"26","author":"Huang","year":"2014","journal-title":"Curr Opin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1053\/j.gastro.2017.03.008","volume":"153","author":"Jiang","year":"2017","journal-title":"Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-016-0559-6","volume":"15","author":"Gautam","year":"2016","journal-title":"Mol Cancer"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.tips.2018.03.004","volume":"39","author":"Matthes","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"ref8","unstructured":"Lexicon Pharmaceuticals, Inc. Xermelo\u00ae (telotristat ethyl) Prescribing Information. 2017. Available from: https:\/\/www.xermelo.com\/Media\/Default\/pdfs\/Product_Info_telotristat_ethyl.pdf. Accessed August 11, 2020."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1200\/JCO.2016.69.2780","volume":"35","author":"Kulke","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1530\/ERC-17-0455","volume":"25","author":"Pavel","year":"2018","journal-title":"Endocr Rel Cancer"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1634\/theoncologist.2018-0921","volume":"24","author":"Strosberg","year":"2019","journal-title":"Oncologist"},{"key":"ref12","unstructured":"Price MA, Joish VN, Schwartz S, et al. XERMELO patient registry: improvements in clinical outcomes, patient satisfaction, and weight with telotristat ethyl in the real-world. In: Annual Symposium of the North American Neuroendocrine Tumor Society; October 3\u20135, 2019; Boston, Massachusetts, Paper no. ID77."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1056\/NEJMoa1316158","volume":"371","author":"Caplin","year":"2014","journal-title":"New Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","volume":"27","author":"Rinke","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1634\/theoncologist.2016-0175","volume":"22","author":"Ter-Minassian","year":"2017","journal-title":"Oncologist"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000443612","volume":"104","author":"Rinke","year":"2017","journal-title":"Neuroendocrinol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1200\/JCO.2020.38.4_suppl.618","volume":"38","author":"Morse","year":"2020","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"6607","DOI":"10.2147\/CMAR.S261257","volume":"12","author":"Morse","year":"2020","journal-title":"Cancer Manag Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/MPA.0000000000001496","volume":"49","author":"Benson","year":"2020","journal-title":"Pancreas"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1159\/000502200","volume":"110","author":"Herrera-Mart\u00ednez","year":"2020","journal-title":"Neuroendocrinol"}],"container-title":["Cancer Management and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=62216","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=62216","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T21:58:13Z","timestamp":1602021493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/survival-and-clinical-outcomes-with-telotristat-ethyl-in-patients-with-peer-reviewed-article-CMAR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":20,"URL":"https:\/\/doi.org\/10.2147\/cmar.s276519","relation":{},"ISSN":["1179-1322"],"issn-type":[{"value":"1179-1322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}